Semaglutide and Papillary Thyroid Carcinoma: Current Evidence on Risk, Progression, and Mechanisms
Preprints.org
- Semaglutide
- GLP-1 receptor agonists
- GLP1R
- GLP-1 and incretin signalling
- Papillary thyroid carcinoma
- Humans
The paper
Barseghyan L, Munir I, Chrysafides S et al.
Preprints.org · 8 Sep 2026 · Preprint, not peer-reviewed
